FDA approves remdesivir for COVID-19
The antiviral drug reduces recovery time but has not been found to cut the risk of dying from COVID-19.
Full Article
FDA approves remdesivir for COVID-19
CBS News
0 shares
1 views
You might like
Related news coverage
New COVID-19 Cases And Hospitalizations Up; Deaths May Follow
Newsy
Watch VideoHospitals are bracing for another surge of COVID-19 patients. In parts of Texas, COVID-19 hospitalizations have roughly..
-
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
-
United States: FDA Approves Veklury (Remdesivir) As The First Treatment For COVID-19 - Seyfarth Shaw LLP
Mondaq
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
Advertisement
More coverage
-
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
-
Biotech Stocks Facing FDA Decision In November 2020
RTTNews
-
Gilead solidifies leadership in COVID-19 treatments with FDA remdesivir nod
SeekingAlpha
-
Huge COVID study finds remdesivir doesn’t work—FDA grants approval anyway
Ars Technica